Name | 2-{[4-(2-Methoxyphenyl)-1-piperazinyl]methyl}-6-methyl-2,6-dihydroimidazo[1,2-c]quinazolin-5(3H)-one |
---|---|
Synonyms |
Imidazo[1,2-c]quinazolin-5(3H)-one, 2,6-dihydro-2-[[4-(2-methoxyphenyl)-1-piperazinyl]methyl]-6-methyl-
2-{[4-(2-Methoxyphenyl)-1-piperazinyl]methyl}-6-methyl-2,6-dihydroimidazo[1,2-c]quinazolin-5(3H)-one 2-{[4-(2-Methoxyphenyl)piperazin-1-yl]methyl}-6-methyl-2,6-dihydroimidazo[1,2-c]quinazolin-5(3H)-one |
Description | 2-MPMDQ is a potent and selective α1-adrenoceptor (Ki=0.37 nM) antagonist over α2-adrenoceptor (Ki=1740 nM). 2-MPMDQ is potent anti-hypertensive agent and has the potential for hypertension research[1]. |
---|---|
Related Catalog | |
Target |
α1-adrenergic receptor:0.37 nM (Ki) α2-adrenergic receptor:1740 nM (Ki) |
References |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 578.2±60.0 °C at 760 mmHg |
Molecular Formula | C23H27N5O2 |
Molecular Weight | 405.49 |
Flash Point | 303.5±32.9 °C |
Exact Mass | 405.216461 |
LogP | 1.60 |
Vapour Pressure | 0.0±1.6 mmHg at 25°C |
Index of Refraction | 1.676 |